Poly-ε-caprolactone (PCL), a promising polymer for pharmaceutical and biomedical applications: Focus on nanomedicine in cancer

Sergio Miguel Espinoza, Harshal Indrabhan Patil, Eduardo San Martin Martinez, Rocio Casañas Pimentel, Pradum Pundlikrao Ige

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

© 2019, © 2019 Taylor & Francis Group, LLC. Poly-ε-caprolactone (PCL) has been the subject of extensive research in the past few years. It is widely explored in drug delivery, where the development of nanomedicines for cancer, one of the major public health concerns nowadays, has not been the exception. As a biocompatible, biodegradable and bioresorbable polymer, PCL has also found plenty of uses in the form of microparticles and scaffolds; so is the main objective of the present review to emphasize its potential and present its properties along with applications in the pharmaceutical and biomedical area with a special focus on nanomedicine in cancer.
Original languageAmerican English
Pages (from-to)85-126
Number of pages42
JournalInternational Journal of Polymeric Materials and Polymeric Biomaterials
DOIs
StatePublished - 22 Jan 2020

Fingerprint

Dive into the research topics of 'Poly-ε-caprolactone (PCL), a promising polymer for pharmaceutical and biomedical applications: Focus on nanomedicine in cancer'. Together they form a unique fingerprint.

Cite this